Following undergraduate graduation, Haydn began a career in academic research at the University of Reading.  The resultant PhD thesis focused on preventing gastreoenteritidis using carbohydrate based ‘nutraceuticals’.  The research was subject to a worldwide patent and was later published across 3 international journals.  Following further years researching Neisseria Meningitidis adhesion mechanisms at Bristol University and Emergent Biosolutions, Haydn joined Lonza Biologics in the Quality Assurance function and implemented a number of Lean Six Sigma process improvement projects before joining MedPharm in 2012.  In his short time as MedPharm’s Quality Assurance Director, he has designed, project-managed and obtained certification of a new MHRA accredited Investigational Medicinal Products manufacturing facility comprising ISO 14644 compliant clean rooms.  He has also conceived and developed a new quality management system to support the new facility.  In his role as Clinical Development Director, he maintains responsibility for strategic management of MedPharm’s manufacturing operation and process improvement projects.

 pharmaceuticals